Cerevel Therapeutics Holdings Inc (CERE)

Track

Stock chart
Ticker: CERE Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-03 2024-07-01 PS Planned sale

COLES N ANTHONY

Non-Executive Director
25,000 -49.1%
41.18
USD 1,029,535 		25,000 -49.1% 41.18 USD 1,029,535
2024-06-05 2024-06-03 PS Planned sale

COLES N ANTHONY

Non-Executive Director
50,000 -76.2%
40.61
USD 2,030,520 		50,000 -76.2% 40.61 USD 2,030,520
2024-05-14 2024-05-10 PS Planned sale

COLES N ANTHONY

Non-Executive Director
50,000 -76.2%
42.10
USD 2,105,125 		50,000 -76.2% 42.10 USD 2,105,125
2024-04-03 2024-04-01 PS Planned sale

COLES N ANTHONY

Non-Executive Director
50,000 -76.2%
42.33
USD 2,116,640 		50,000 -76.2% 42.33 USD 2,116,640
2024-03-06 2024-03-04 PS Planned sale

COLES N ANTHONY

Non-Executive Director
50,000 -76.2%
41.01
USD 2,050,550 		50,000 -76.2% 41.01 USD 2,050,550
2024-03-04 2024-02-29 PS Planned sale

COLES N ANTHONY

Non-Executive Director
50,000 -76.2%
41.16
USD 2,057,890 		50,000 -76.2% 41.16 USD 2,057,890
2024-02-08 2024-02-07 S Sale

COLES N ANTHONY

Non-Executive Director
2,506 -13.8%
41.54
USD 104,110 		2,506 -13.8% 41.54 USD 104,110
2024-02-08 2024-02-07 S Sale

Renger John

Chief Scientific Officer

Officer
2,161 -25.3%
41.54
USD 89,777 		2,161 -25.3% 41.54 USD 89,777
2024-01-04 2024-01-02 PS Planned sale

COLES N ANTHONY

Non-Executive Director
50,000 -94.9%
42.24
USD 2,111,815 		50,000 -94.9% 42.24 USD 2,111,815
2023-12-28 2023-12-26 PS Planned sale

Sanchez Ramiro

Chief Medical Officer

Officer
10,000 -40.5%
42.47
USD 424,700 		10,000 -40.5% 42.47 USD 424,700
2023-12-27 2023-12-22 S Sale

DiPietro Kenneth

Chief Human Resources Officer

Officer
8,000 -24.5%
41.45
USD 331,608 		8,000 -24.5% 41.45 USD 331,608
2023-12-21 2023-12-20 S Sale

Akamine Scott

Chief Legal Officer

Officer
7,072 -49.4%
41.42
USD 292,945 		7,072 -49.4% 41.42 USD 292,945
2023-12-21 2023-12-20 S Sale

Bodenrader Mark

See Remarks

Officer
7,889 -30.8%
41.42
USD 326,788 		7,889 -30.8% 41.42 USD 326,788
2023-12-21 2023-12-20 S Sale

Tregoning Kathleen

See Remarks

Officer
6,288 -45.6%
41.42
USD 260,469 		6,288 -45.6% 41.42 USD 260,469
2023-12-21 2023-12-20 S Sale

ALTSCHULLER Susan

Chief Financial Officer

Officer
13,808 -44.9%
41.42
USD 571,972 		13,808 -44.9% 41.42 USD 571,972
2023-12-21 2023-12-20 S Sale

Sanchez Ramiro

Chief Medical Officer

Officer
10,152 -40.9%
41.42
USD 420,528 		10,152 -40.9% 41.42 USD 420,528
2023-12-21 2023-12-20 S Sale

DiPietro Kenneth

Chief Human Resources Officer

Officer
6,256 -20.2%
41.42
USD 259,144 		6,256 -20.2% 41.42 USD 259,144
2023-12-19 2023-12-15 S Sale

Sanchez Ramiro

Chief Medical Officer

Officer
7,500 -100.0%
41.39
USD 310,393 		7,500 -100.0% 41.39 USD 310,393
2023-12-11 2023-12-07 PS Planned sale

Sanchez Ramiro

Chief Medical Officer

Officer
10,000 -100.0%
41.37
USD 413,700 		10,000 -100.0% 41.37 USD 413,700
2023-12-07 2023-12-07 PS Planned sale

Akamine Scott

Chief Legal Officer

Officer
10,000 -95.1%
41.37
USD 413,700 		10,000 -95.1% 41.37 USD 413,700
// ... existing code ...